Trials / Completed
CompletedNCT01206452
Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes
Use of Oral Steroids Before Circumferential Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation to Improve Outcomes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Dhanunjaya Lakkireddy, MD, FACC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.
Detailed description
The purpose of this study is: 1. To assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation. 2. To measure the inflammatory cytokine (TNF-α, IL-1, IL-6, IL-8) response to radiofrequency ablation for atrial fibrillation with or without prior prednisone treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisone | 60mg of oral prednisone 2 days before procedure, day of procedure, and 1 day after procedure |
| OTHER | Placebo | 60mg placebo pill given 2 days before procedure, day of procedure, and 1 day after procedure |
| PROCEDURE | Ablation Procedure | Atrial Fibrillation (AF) ablation |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2010-09-21
- Last updated
- 2017-05-17
- Results posted
- 2017-05-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01206452. Inclusion in this directory is not an endorsement.